MetaCap

Aardvark Therapeutics Inc. Company Profile

NASDAQ: AARDHealthcareBiotechnologyUSD

4.71-0.25 (-5.04%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Aardvark Therapeutics at a glance

Aardvark Therapeutics Inc. (NASDAQ: AARD) is a Biotechnology company in the Healthcare sector headquartered in San Diego, CA. Aardvark Therapeutics is led by Dr. Tien-Li Lee M.D. and employs about 28 people. The company's shares have traded publicly since 2025.

At a market capitalization of $103.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001774857, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Aardvark Therapeutics do?

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
Aardvark Therapeutics Inc.
Ticker
NASDAQ: AARD
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Tien-Li Lee M.D.
Employees
28
Headquarters
4370 La Jolla Village Drive, San Diego, CA, United States
Phone
858 225 7696
Website
aardvarktherapeutics.com
IPO year
2025
Market cap
$103.08M
SEC CIK
0001774857

Companies similar to Aardvark Therapeutics

AARD peer companies
CompanyPrice% ChgMarket capCompare
IMUXImmunic Inc.7.56-0.92%$103.15Mvs AARD
BDTXBlack Diamond Therapeutics Inc.1.81-1.09%$103.72Mvs AARD
CRBPCorbus Pharmaceuticals Holdings Inc.5.27-4.01%$101.93Mvs AARD
ANIXAnixa Biosciences Inc.2.91-1.36%$101.16Mvs AARD
KZIAKazia Therapeutics Limited ADR8.82-5.06%$100.79Mvs AARD
PLYXPolaryx Therapeutics Inc.2.00-4.31%$99.69Mvs AARD
PYPDPolyPid Ltd.4.90-1.01%$99.53Mvs AARD
BMEABiomea Fusion Inc.1.37+3.79%$99.05Mvs AARD

Related